PGA Tour

Nico Echavarria wins Cognizant Classic in The Palm Beaches with flawless weekend after Shane Lowry melts down late

Nico Echavarria didn't make a bogey all weekend. Shane Lowry was on his way to doing the same, until the very end.

Shane Lowry’s two-hole tailspin gives Nico Echavarria the Cognizant Classic win

The “Bear Trap” caught Shane Lowry and gave Nico Echavarria the Cognizant Classic win.

Shane Lowry and Austin Smotherman tied for the Cognizant Classic lead at 13 under

Shane Lowry has yet another chance to win at PGA National. The native of Ireland who now calls South Florida home had a bogey ...

Badenoch says student loans system at 'breaking point' as PM to 'look at ways to make it fairer'

The Tory leader says the student loan system is at "breaking point" as the PM says his government will "look at ways to make ...
NPR

FDA reverses course on Moderna flu shot

The Food and Drug Administration rattled the biotech industry last week when it said it wouldn't even look at Moderna's application to market the first mRNA flu shot. But on Wednesday, the agency ...
AOL

Moderna stock surges as FDA reverses course, agrees to review new flu shot

Moderna (MRNA) stock jumped more than 6% on Wednesday after the US Food and Drug Administration agreed to review the drugmaker's first flu shot of the season, reversing course on a decision to reject ...
Wall Street Journal

FDA Reverses Course and Will Now Review Moderna’s Flu Shot

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA1.68%increase; green up pointing triangle application to sell a new seasonal flu shot after the vaccine ...
Houston Public Media

FDA reverses course on Moderna flu shot

The Food and Drug Administration said it would review vaccine maker Moderna's application for a new kind of flu shot after the company agreed to further study it in older people. (Bill Sikes | AP) The ...
Alaska Dispatch News

FDA reverses course, will consider Moderna’s new flu shot for older adults

WASHINGTON — The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the ...
BioSpace

FDA Reverses Course on Moderna’s mRNA Flu Shot Application, Promising August Decision

The disagreement between Moderna and the FDA has reached a resolution just eight days after the biotech received a Refusal-to-File letter in response to its application for mRNA-1010. Moderna will now ...
CNN

FDA reverses course and will review Moderna’s mRNA flu shot, company says

The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday. About two weeks ago, the FDA sent Moderna a ...
Hosted on MSN

FDA reverses course, will review Moderna flu shot

The FDA has reversed course and will review a new mRNA flu vaccine from Moderna, the company announced Wednesday. American manufacturer’s hidden tag calling president "idiot" resurfaces The ...